ATP P(2X) receptors play little role in the maintenance of neuropathic hyperalgesia

NeuroReport

Volumn 11, Issue 8, 2000, Pages 1669-1672

  Liu, Tao ^a   Tracey, David J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

ATP receptors; Behavior; Nerve injury; Thermal hyperalgesia

Indexed keywords

PURINE P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; DRUG DERIVATIVE; PURINE P2 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; IMMOBILIZATION; MALE; NEUROPATHY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; THERMAL STIMULATION; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HEAT; INJURY; INTRASPINAL DRUG ADMINISTRATION; LIGATION; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SPINAL CORD; WISTAR RAT;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; HYPERALGESIA; INJECTIONS, SPINAL; LIGATION; MALE; MOTOR ACTIVITY; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; SCIATIC NERVE; SPINAL CORD; SURAMIN; WOUNDS AND INJURIES;

EID: 0034608116     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200006050-00015     Document Type: Article

References (25)

1. 1. Kingery WS. Pain 73, 123-139 (1997).
2. 2. Tracey DJ and Walker JS. Inflamm Res 44, 407-411 (1995).
3. 3. Brake A, Schumacher M and Julius D. Chem Biol 3, 229-232 (1996).
4. 4. Burnstock G and Wood JN. Curr Opin Neurobiol 6, 526-532 (1996).
5. 5. Sawynok J and Reid A. Eur J Pharmacol 330, 115-121 (1997).
6. 6. Burnstock G. Lancet 347, 1604-1605 (1996).
7. 7. Robertson SJ, Rae MC, Rowan EG and Kennedy C. Br J Pharmacol 118, 951-956 (1996).
8. 8. Abbracchio MP and Burnstock G. Pharmacol Therapeut 64, 445-475 (1994).
9. 9. MacKenzie AB, Surprenant A and North RA. Ann NY Acad Sci 868, 716-729 (1999).
10. 10. Xiang Z, Bo X and Burnstock G. Neurosci Lett 256, 105-108 (1998).
11. 11. Chen CC, Akopian AN, Sivilotti L et al. Nature 377, 428-431 (1995).
12. 12. Lewis C, Neidhart S, Holy C et al. Nature 377, 432-435 (1995).
13. 13. Llewellyn-Smith IJ and Burnstock G. Neuroreport 9, 2545-2550 (1998).
14. 14. Novakovic SD, Kassotakis LC, Oglesby IB et al. Pain 80, 273-282 (1999).
15. 15. Eriksson J, Bongenhielm U, Kidd E et al. Neurosci Lett 254, 37-40 (1998).
16. 16. Balcar VJ, Dias LS, Li Y and Bennett MR. Neuroreport 7, 69-72 (1995).
17. 17. Brizzolara AL, Crowe R and Burnstock G. Br J Pharmacol 109, 606-608 (1993).
18. 18. Ziganshin AU, Hoyle CH, Bo X et al. Br J Pharmacol 110, 1491-1495 (1993).
19. 19. Seltzer Z, Dubner R and Shir Y. Pain 43, 205-218 (1990).
20. 20. Hargreaves K, Dubner R, Brown F et al. Pain 32, 77-88 (1988).
21. 21. Cook SP, Vulchanova L, Hargreaves KM et al. Nature 387, 505-508 (1997).
22. 22. Driessen B, Reimann W, Selve N et al. Brain Research 666, 182-188 (1994).
23. 23. Li P, Calejesan AA and Zhuo M. J Neurophysiol 80, 3356-3360 (1998).
24. 24. Stebbing MJ, McLachlan EM and Sah P. Neuroscience 86, 1235-1244 (1998).
25. 25. Stanfa LC, Kontinen VK and Dickenson AH. Br J Pharmacol 129, 351-359 (2000).